Article Information
History
- March 24, 2022.
Article Versions
- Version 1 (March 21, 2022 - 13:13).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rebekkah J. Hitti-Malin1,2,*,
- Claire-Marie Dhaenens3,
- Daan M. Panneman1,2,
- Zelia Corradi1,2,
- Mubeen Khan1,
- Anneke I. den Hollander4,
- G. Jane Farrar5,
- Christian Gilissen1,6,
- Alexander Hoischen1,6,7,
- Maartje van de Vorst1,
- Femke Bults1,
- Erica G.M. Boonen1,
- Patrick Saunders8,
- MD Study Group†,
- Susanne Roosing1,2 and
- Frans P.M. Cremers1,2
- 1Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands
- 2Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands
- 3Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France
- 4Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands
- 5The School of Genetics & Microbiology, The University of Dublin Trinity College, Dublin, Ireland
- 6Radboud Institute of Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands
- 7Radboud University Medical Center for Infectious Diseases (RCI), Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
- 8Molecular Loop Biosciences Inc., Newton, MA, USA
- ↵*Corresponding author; email: rebekkah.hitti-malin{at}radboudumc.nl
Posted March 24, 2022.
Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseases
